Abstract
Hyperkalaemia is a lifethreatening emergency and infusion of glucose with insulin has so far been regarded as the standard treatment of choice. Recently the β-2 stimulatory drug salbutamol has been shown to be an effective agent to treat hyperkalaemia by inducing a shift of potassium into the intracellular compartment. We treated 15 children aged 0.1–14 (mean 5.2) years suffering from acute hyperkalaemia (mean level 6.6±0.54, range 5.9–7.7 mmol/l) with a single infusion of salbutamol (5 μg/kg over 15 min). Serum potassium concentrations decreased significantly within 30 min to levels of 5.74±0.53 and 4.92±0.53 mmol/l after 120 min (P<0.001, respectively). No side-effects occurred other than a slight increase in heart rate in 3 patients.
Conclusion
A single intravenous infusion of salbutamol at a dose of 5 μg/kg is a highly effective treatment for hyperkalaemia with minimal clinical side-effects. The effect lasts for at least 120 min and may reverse hyperkalaemia in some patients without further interventions so that salbutamol seems justified as the first choice treatment for this condition in childhood.
Similar content being viewed by others
References
Allon M (1993) Treatment and prevention of hyperkalemia. Kidney Int 43: 1197–1209
Allon M, Copkney C (1990) Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 38: 869–872
Blumberg A, Wiedmann P, Shaw S, Gnadinger M (1988) Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 85: 507–512
Brown MJ, Brown DC, Murphy MB (1983) Hypokalemia from circulating beta-2 receptor stimulation by circulating epinephrine. N Engl J Med 309: 1414–1419
Clausen T, Everts ME (1989) Regulation of the Na−K pump in skeletal muscle. Kidney Int 35: 1–13
Conte G, Dal Canton A, Imperatore P, et al (1990) Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int 38: 301–307
Lens XM, Montoliu J, Cases A, Campistol JM, Revert L (1989) Treatment of hyperkalemia in renal failure: salbutamol vs. insulin. Nephrol Dial Transplant 4: 228–232
Liou H-H, Chiang S-S, Wu S-C, Huang T-P, Campese V M, Smorgorzewski M, Yang W-C (1994) Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis 23: 266–271
McClure RJ, Prasad VK, Brocklebank JT (1994) Treatment of hyperkalemia using intravenous and nebulised salbutamol. Arch Dis Child 70: 126–128
Murdoch I A, Dos Anjos R, Haycock G B (1991) Treatment of hyperkalaemia with intravenous salbutamol. Arch Dis Child 66: 527–528
Poole-Wilson PA, Cameron IR (1975) Intracellular pH and K+ of cardiac and skeletal muscle in acidosis and alkalosis. Am J Physiol 229: 1305–1320
Wang P, Clausen T (1976) Treatment of attacks in hyperkalemic familial periodic paralysis by inhalation of salbutamol. Lancet 1: 221–223
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kemper, M.J., Harps, E., Hellwege, H.H. et al. Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol. Eur J Pediatr 155, 495–497 (1996). https://doi.org/10.1007/BF01955188
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01955188